BioSpace News Archive

Pharm Country

Teleflex to Present at the Jefferies London Healthcare Conference

Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Jefferies London Healthcare Conference, on Tuesday, November 15, 2022, at 2:40 p.m. (GMT).

November 1, 2022
·
1 min read
Affimed to Present at the 2022 Jefferies London Healthcare Conference

Affimed N.V. announced that its Chief Executive Officer, Dr. Adi Hoess, will present at the 2022 Jefferies London Healthcare Conference on Wednesday, November 16, 2022, at 12:55 p.m. GMT / 7:55 a.m. EST / 13:55 CET.

November 1, 2022
·
1 min read
Business

Pyxis Oncology Reports Financial Results for the Quarter Ended September 30, 2022 and Provides Corporate Update

Pyxis Oncology, Inc. reported financial results for the third quarter and nine months ended September 30, 2022 and provided a corporate update.

November 1, 2022
·
9 min read
Business

Bio-Techne Releases First Quarter Fiscal 2023 Results

Bio-Techne Corporation reported its financial results for the first quarter ended September 30, 2022.

November 1, 2022
·
20 min read
BioMidwest

Bio-Techne Declares Cash Dividend and Stock Dividend payable November 28, 2022

Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2022.

November 1, 2022
·
2 min read
Business

IDEXX Laboratories Announces Third Quarter 2022 Results

IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced third quarter results and an update on U.S. companion animal diagnostics trends.

November 1, 2022
·
33 min read
Drug Development

Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate

Pfizer Inc. announced positive top-line data from the Phase 3 clinical trial MATISSE investigating its bivalent RSV prefusion vaccine candidate, RSVpreF or PF-06928316, when administered to pregnant participants to help protect their infants from RSV disease after birth.

November 1, 2022
·
12 min read
Genetown

Karuna Therapeutics to Present at the Jefferies 2022 London Healthcare Conference

Karuna Therapeutics, Inc. announced that Troy Ignelzi, chief financial officer of Karuna Therapeutics, will participate in a fireside chat at the Jefferies 2022 London Healthcare Conference on Wednesday, November 16, 2022, at 3:50 p.m. GMT.

November 1, 2022
·
1 min read
Business

ImmunoGen Announces Departure of Chief Commercial Officer - November 01, 2022

ImmunoGen, Inc., a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, announced that Kristen Harrington-Smith, Senior Vice President and Chief Commercial Officer, will be departing the Company.

November 1, 2022
·
4 min read
Business

Quest Diagnostics Completes Leadership Succession as Jim Davis Becomes CEO and President, Joins Board of Directors

Quest Diagnostics announced that Jim Davis has succeeded Steve Rusckowski as the CEO and President of Quest Diagnostics, completing a transition first announced on February 3, 2022.

November 1, 2022
·
2 min read